Price and welfare effects of a pharmaceutical substitution reform

被引：17

作者：

Granlund, David ^{[1
,2
]}

机构：

[1] Umea Univ, Dept Econ, S-90187 Umea, Sweden

[2] Swedish Retail Inst HUI, S-10329 Stockholm, Sweden

来源：

JOURNAL OF HEALTH ECONOMICS | 2010年 / 29卷 / 06期

关键词：

Drugs; Generic competition; Equivalent variation; Demand estimation; GENERIC SUBSTITUTION; COMPETITION; ENTRY; EXPENDITURES; COUNTRIES; INDUSTRY; IMPACT;

D O I：

10.1016/j.jhealeco.2010.08.003

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a panel of all pharmaceutical product sold in Sweden in 1997-2007 The price reduction due to the reform was estimated to average 10% and was found to be significantly larger for brand-name pharmaceuticals than for generics The results also imply that the reform amplified the effect that generic entry has on brand-name prices by a factor of 10 Results of a demand estimation imply that the price reductions increased total pharmaceutical consumption by 8% and consumer welfare by SEK 2 7 billion annually (C) 2010 Elsevier B V All rights reserved

引用

页码：856 / 865

页数：10

共 26 条

[1] ESTIMATES OF THE DEMAND FOR ETHICAL PHARMACEUTICAL DRUGS ACROSS COUNTRIES AND TIME [J].

ALEXANDER, DL ;

FLYNN, JE ;

LINKINS, LA .

APPLIED ECONOMICS, 1994, 26 (08) :821-826

[2] What are the obstacles to generic substitution?: An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden [J].

Andersson, K ;

Sonesson, C ;

Petzold, M ;

Carlsten, A ;

Lönroth, K .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (05) :341-348

[3] Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals [J].

Andersson, Karolina ;

Bergstrom, Gina ;

Petzold, Max G. ;

Carlsten, Anders .

HEALTH POLICY, 2007, 81 (2-3) :376-384

[4] Physicians' opinions and experiences of the pharmaceutical benefits reform [J].

Andersson, Karolina ;

Jorgensen, Tove ;

Carlsten, Anders .

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2006, 34 (06) :654-659

[5]

Buzzelli C, 2006, J PHARM FINANC ECON, V5, P41, DOI DOI 10.1300/J371v15n01_06

[6]

CAVES RE, 1991, BROOKINGS PAP ECO AC, P1

[7] Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India [J].

Chaudhuri, Shubham ;

Goldberg, Pinelopi K. ;

Jia, Panle .

AMERICAN ECONOMIC REVIEW, 2006, 96 (05) :1477-1514

[8] PRICING, PATENT LOSS AND THE MARKET FOR PHARMACEUTICALS [J].

FRANK, RG ;

SALKEVER, DS .

SOUTHERN ECONOMIC JOURNAL, 1992, 59 (02) :165-179

[9] Generic entry and the pricing of pharmaceuticals [J].

Frank, RG ;

Salkever, DS .

JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 1997, 6 (01) :75-90

[10] Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures [J].

Getzen, TE .

JOURNAL OF HEALTH ECONOMICS, 2000, 19 (02) :259-270

← 1 2 3 →